{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:02:32Z","timestamp":1790809352989,"version":"4.1.0"},"reference-count":133,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health USA","doi-asserted-by":"crossref","award":["R01 DK54830"],"award-info":[{"award-number":["R01 DK54830"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Plexcera Therapeutics LLC"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.bbadis.2016.05.001","type":"journal-article","created":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T22:11:17Z","timestamp":1462399877000},"page":"1459-1471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Acid ceramidase and the treatment of ceramide diseases: The expanding role of enzyme replacement therapy"],"prefix":"10.1016","volume":"1862","author":[{"given":"Edward H.","family":"Schuchman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2016.05.001_bb0005","series-title":"A Treatise on the Chemical Constitution of Brain","author":"Thudichum","year":"1884"},{"issue":"8 Part B","key":"10.1016\/j.bbadis.2016.05.001_bb0010","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.bbalip.2015.12.021","article-title":"Taming the sphinx: mechanisms of cellular sphingolipid homeostasis","volume":"1861","author":"Olson","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"Suppl. 1","key":"10.1016\/j.bbadis.2016.05.001_bb0015","first-page":"11","article-title":"Trafficking and functions of bioactive sphingolipids: lessons from cells and model membranes","volume":"8","author":"Zhou","year":"2015","journal-title":"Lipid Insights"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0020","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.bbalip.2008.06.002","article-title":"Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate","volume":"1781","author":"Mao","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0025","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1016\/S0021-9258(18)51879-2","article-title":"Enzymic hydrolysis and synthesis of ceramides","volume":"238","author":"Gatt","year":"1963","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0030","series-title":"Subcellular Particles","first-page":"128","article-title":"Lysosomes, a new group of cytoplasmic particles","author":"De Duve","year":"1959"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0035","doi-asserted-by":"crossref","first-page":"11098","DOI":"10.1074\/jbc.270.19.11098","article-title":"Purification, characterization, and biosynthesis of human acid ceramidase","volume":"270","author":"Bernardo","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0040","doi-asserted-by":"crossref","first-page":"35352","DOI":"10.1074\/jbc.M103066200","article-title":"Human acid ceramidase: processing, glycosylation, and lysosomal targeting","volume":"276","author":"Ferlinz","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0045","doi-asserted-by":"crossref","first-page":"32978","DOI":"10.1074\/jbc.M301936200","article-title":"Purification and characterization of recombinant, human acid ceramidase. Catalytic reactions and interactions with acid sphingomyelinase","volume":"278","author":"He","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0050","doi-asserted-by":"crossref","first-page":"11253","DOI":"10.1074\/jbc.M709166200","article-title":"Autoproteolytic cleavage and activation of human acid ceramidase","volume":"283","author":"Shtraizent","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0055","doi-asserted-by":"crossref","first-page":"27855","DOI":"10.1074\/jbc.R111.254359","article-title":"Many ceramides","volume":"286","author":"Hannun","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0060","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1074\/jbc.M006846200","article-title":"Interfacial regulation of acid ceramidase activity. Stimulation of ceramide degradation by lysosomal lipids and sphingolipid activator proteins","volume":"276","author":"Linke","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0065","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/1873-3468.12104","article-title":"Lysosomal glycosphingolipid catabolism by acid ceramidase: formation of glycosphingoid bases during deficiency of glycosidases","volume":"59","author":"Ferraz","year":"2016","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0070","doi-asserted-by":"crossref","first-page":"29948","DOI":"10.1074\/jbc.M303310200","article-title":"The reverse activity of human acid ceramidase","volume":"278","author":"Okino","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0075","first-page":"499","article-title":"A lipid metabolic disorder \u2013 disseminated \u201clipogranulomatosis\u201d \u2013 a syndrome with similarity to, and important difference from, Niemann\u2013Pick and Hand\u2013Schuller\u2013Christian disease","volume":"84","author":"Farber","year":"1952","journal-title":"Am. J. Dis. Child."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0080","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1148\/74.3.428","article-title":"Disseminated lipogranulomatosis. Report of a case","volume":"74","author":"Schultze","year":"1960","journal-title":"Radiology"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0085","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1651-2227.1958.tb07665.x","article-title":"Disseminated lipogranulomatosis (Farber's disease)","volume":"47","author":"Zetterstrom","year":"1958","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0090","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1126\/science.178.4065.1100","article-title":"(Ceramidase deficiency in Farbers disease (lipogranulomatosis)","volume":"178","author":"Sugita","year":"1972","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0095","series-title":"The Metabolic and Molecular Basis of Inherited Disease","first-page":"820","article-title":"Acid ceramidase deficiency: Farber's lipogranulomatosis","author":"Moser","year":"2001"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0100","series-title":"Scriver's Online Metabolic and Molecular Basis of Human Disease","article-title":"Acid ceramidase deficiency: Farber lipogranulomatosis","author":"Levade","year":"2009"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF02024331","article-title":"Sphingolipid activtro protein deficiency in a 16-week-old Gaucher disease patient and his fetal sibling. Biochemcial signs of combined sphingolipidoses","volume":"149","author":"Harzer","year":"1989","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0110","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1016\/S0021-9258(19)50733-5","article-title":"Simultaneous deficiency of sphingolipid activator proteins-1 and proteins-2 is caused by a mutation in the initiation codon of their common gene","volume":"267","author":"Schnabel","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0115","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1006\/abbi.1994.1248","article-title":"Stimulation of acid ceramidase activity by saposin-D","volume":"311","author":"Azuma","year":"1994","journal-title":"Arch. Biochem. Biophys."},{"issue":"3","key":"10.1016\/j.bbadis.2016.05.001_bb0120","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/humu.5","article-title":"Molecular analysis of acid ceramidase deficiency in patients with Farber disease","volume":"17","author":"Bar","year":"2001","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0125","first-page":"116","article-title":"Hereditary myoclonus and progessive muscular atrophy: a new syndrome","volume":"103","author":"Jankociv","year":"1978","journal-title":"Trans. Am. Neurol. Assoc."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0130","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ajhg.2012.05.001","article-title":"Spinal muscular atrophy associated with progressive myoclonic epilepsy is caused by mutations in asah1","volume":"91","author":"Zhou","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0135","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/cge.12307","article-title":"Evidence for clinical, genetic and biochemical variability in spinal muscular atrophy with progressive myoclonic epilepsy","volume":"86","author":"Dyment","year":"2014","journal-title":"Clin. Genet."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0140","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.nmd.2015.09.007","article-title":"Acid ceramidase deficiency associated with spinal muscular atrophy with progressive myoclonic epilepsy","volume":"25","author":"Gan","year":"2015","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0145","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/epi.12977","article-title":"Spinal muscular atrophy associated with progressive myoclonic epilepsy: a rare condition caused by mutations in ASAH1","volume":"56","author":"Rubboli","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/art.39659","article-title":"Peripheral osteolysis in adults linked to ASAH1 (acid ceramidase) mutations: a new presentation of Farber disease","author":"Bonafe","year":"2016","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0155","doi-asserted-by":"crossref","first-page":"33110","DOI":"10.1074\/jbc.271.51.33110","article-title":"Molecular cloning and characterization of a full-length complementary DNA encoding human acid ceramidase. Identification of the first molecular lesion causing Farber disease","volume":"271","author":"Koch","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0160","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/geno.1999.5940","article-title":"The human acid ceramidase gene (asah): structure, chromosomal location, mutation analysis, and expression","volume":"62","author":"Li","year":"1999","journal-title":"Genomics"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0165","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.braindev.2011.09.006","article-title":"A novel mutation in an atypical presentation of the rare infantile Farber disease","volume":"34","author":"Al Jasmi","year":"2012","journal-title":"Brain Dev."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0170","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/cge.12316","article-title":"Molecular analyses of novel ASAH1 mutations causing Farber lipogranulomatosis: analyses of exonic splicing enhancer inactivating mutation","volume":"86","author":"Bashyam","year":"2014","journal-title":"Clin. Genet."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0175","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ymgme.2013.04.019","article-title":"Molecular basis of acid ceramidase deficiency in a neonatal form of Farber disease: identification of the first large deletion in ASAH1 gene","volume":"109","author":"Alves","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0180","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/humu.5","article-title":"Molecular analysis of acid ceramidase deficiency in patients with Farber disease","volume":"17","author":"Bar","year":"2001","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0185","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1016\/S0021-9258(18)99832-7","article-title":"Enzymatic hydrolysis of sphingolipids. I. Hydrolysis and synthesis of ceramides by an enzyme from rat brain","volume":"241","author":"Gatt","year":"1966","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0190","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1515\/BC.2007.152","article-title":"Overexpression and mass spectrometry analysis of mature human acid ceramidase","volume":"388","author":"Schulze","year":"2007","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0195","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1006\/geno.1998.5334","article-title":"Cloning and characterization of the full-length cDNA and genomic sequences encoding murine acid ceramidase","volume":"50","author":"Li","year":"1998","journal-title":"Genomics"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0200","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1006\/geno.2002.6686","article-title":"Insertional mutagenesis of the mouse acid ceramidase gene leads to early embryonic lethality in homozygotes and progressive lipid storage disease in heterozygotes","volume":"79","author":"Li","year":"2002","journal-title":"Genomics"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0205","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1096\/fj.06-7016com","article-title":"Acid ceramidase is a novel factor required for early embryo survival","volume":"21","author":"Eliyahu","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0210","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1096\/fj.09-145508","article-title":"Acid ceramidase improves the quality of oocytes and embryos and the outcome of in vitro fertilization","volume":"24","author":"Eliyahu","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0215","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1159\/000341453","article-title":"Construction of conditional acid ceramidase knockout mice and in vivo effects on oocyte development and fertility","volume":"30","author":"Eliyahu","year":"2012","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0220","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/emmm.201202301","article-title":"Systemic ceramide accumulation leads to severe and varied pathological consequences","volume":"5","author":"Alayoubi","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0225","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.3324\/haematol.2014.108530","article-title":"Markedly perturbed hematopoiesis in acid ceramidase deficient mice","volume":"100","author":"Dworski","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0230","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev-med-122313-085916","article-title":"Lysosomal storage diseases: from pathophysiology to therapy","volume":"66","author":"Parenti","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0235","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40259-015-0116-7","article-title":"Enzymes approved for human therapy: indications, mechanisms and adverse effects","volume":"29","author":"Baldo","year":"2015","journal-title":"BioDrugs"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0240","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10545-014-9718-3","article-title":"Treatment of lysosomal storage disorders: successes and challenges","volume":"37","author":"Hollak","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0245","doi-asserted-by":"crossref","DOI":"10.1517\/14728214.2016.1123690","article-title":"Emerging drugs for the treatment of mucopolysaccharidoses","author":"Giugliani","year":"2016","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0250","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1089\/10430349950018003","article-title":"Retrovirus-mediated correction of the metabolic defect in cultured Farber disease cells","volume":"10","author":"Medin","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0255","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/0091270010394852","article-title":"Efficacy of antidepressants as analgesics: a review","volume":"52","author":"Dharmshaktu","year":"2012","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0260","article-title":"Inhibitors of ceramidases","author":"Saied","year":"2015","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0265","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.beem.2015.01.001","article-title":"Innovative treatments for lysosomal diseases","volume":"29","author":"Cox","year":"2015","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0270","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/rheumatology\/keu010","article-title":"Farber disease in infancy resembling juvenile idiopathic arthritis: identification of two new mutations and a good early response to allogeneic haematopoietic stem cell transplantation","volume":"53","author":"Torcoletti","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0275","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s00431-013-2098-0","article-title":"Odontoid infiltration and spinal compression in Farber disease: reversal by haematopoietic stem cell transplantation","volume":"173","author":"Jarisch","year":"2014","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0280","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10545-015-9890-0","article-title":"Nervous system involvement in Farber disease","volume":"39","author":"Cappellari","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"issue":"91","key":"10.1016\/j.bbadis.2016.05.001_bb0285","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0092-8674(00)80448-1","article-title":"Acidic sphingomyelinase mediates entry of N. gonorrhoeae into nonphagocytic cells","volume":"28","author":"Grassm\u00e9","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0290","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1515\/hsz-2014-0285","article-title":"Ceramide and sphingosine in pulmonary infections","volume":"396","author":"Seitz","year":"2015","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0295","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/42408","article-title":"Functional rafts in cell membranes","volume":"387","author":"Simons","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0300","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev.cellbio.14.1.111","article-title":"Functions of lipid rafts in biological membranes","volume":"14","author":"Brown","year":"1998","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0305","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/1097-4652(200009)184:3<285::AID-JCP2>3.0.CO;2-3","article-title":"Compartmentalization of ceramide signaling: physical foundations and biological effects","volume":"184","author":"Kolesnick","year":"2000","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0310","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nm823","article-title":"Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts","volume":"9","author":"Grassm\u00e9","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0315","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.4049\/jimmunol.0902851","article-title":"Alterations in ceramide concentration and pH determine the release of reactive oxygen species by Cftr-deficient macrophages on infection","volume":"184","author":"Zhang","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0320","doi-asserted-by":"crossref","first-page":"E1614","DOI":"10.1073\/pnas.1421190112","article-title":"CFTR and sphingolipids mediate hypoxic pulmonary vasoconstriction","volume":"112","author":"Tabeling","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0325","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1086\/675989","article-title":"Loss of cystic fibrosis transmembrane conductance regulator impairs lung endothelial cell barrier function and increases susceptibility to microvascular damage from cigarette smoke","volume":"4","author":"Brown","year":"2014","journal-title":"Pulm. Circ."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0330","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nm1748","article-title":"Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis","volume":"14","author":"Teichgr\u00e4ber","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0335","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/978-3-7091-1511-4_13","article-title":"Ceramide in cystic fibrosis","volume":"216","author":"Grassm\u00e9","year":"2013","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0340","article-title":"A scoping review of healthcare costs for patients with cystic fibrosis","author":"Hollin","year":"2015","journal-title":"Appl. Health Econ. Health Policy"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0345","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/QCO.0000000000000217","article-title":"Managing Pseudomonas aeruginosa respiratory infections in cystic fibrosis","volume":"28","author":"Langan","year":"2015","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0350","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1165\/ajrcmb.11.6.7946394","article-title":"Pseudomonas stimulates interleukin-8 mRNA expression selectively in airway epithelium, in gland ducts, and in recruited neutrophils","volume":"11","author":"Inoue","year":"1994","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0355","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1164\/ajrccm.152.6.8520783","article-title":"Inflammatory cytokines in cystic fibrosis lungs","volume":"152","author":"Bonfield","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0360","first-page":"er20151026","article-title":"Growth and the growth hormone-insulin like growth factor 1 axis in children with chronic inflammation: current evidence, gaps in knowledge and future directions","volume":"31","author":"Wong","year":"2015","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0365","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000362983","article-title":"Regulation of the inflammasome by ceramide in cystic fibrosis lungs","volume":"34","author":"Grassm\u00e9","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0370","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1164\/rccm.200905-0799OC","article-title":"Ceramide is increased in the lower airway epithelium of people with advanced cystic fibrosis lung disease","volume":"182","author":"Brodlie","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0375","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jcf.2010.03.001","article-title":"Aveolar inflammation in cystic fibrosis","volume":"9","author":"Ulrich","year":"2010","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0380","doi-asserted-by":"crossref","first-page":"602","DOI":"10.4049\/jimmunol.1002850","article-title":"Critical modifier role of membrane-cystic fibrosis transmembrane conductance regulator-dependent ceramide signaling in lung injury and emphysema","volume":"186","author":"Bodas","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0385","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.bbagen.2013.10.018","article-title":"Anti-inflammatory action of lipid nanocarrier-delivered myriocin: therapeutic potential in cystic fibrosis","volume":"1840","author":"Caretti","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0390","doi-asserted-by":"crossref","first-page":"C819","DOI":"10.1152\/ajpcell.00168.2013","article-title":"Reduced GM1 ganglioside in CFTR-deficient human airway cells results in decreased \u03b21-integrin signaling and delayed wound repair","volume":"306","author":"Itokazu","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0395","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1159\/000350071","article-title":"Therapy of CF-patients with amitriptyline and placebo\u2014a randomised, double-blind, placebo-controlled phase IIb multicenter, cohort-study","volume":"31","author":"N\u00e4hrlich","year":"2013","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0400","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.15252\/emmm.201404075","article-title":"Sphingoid long chain bases prevent lung infection by Pseudomonas aeruginosa","volume":"6","author":"Pewzner-Jung","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0405","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrneph.2015.173","article-title":"Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease","volume":"12","author":"Thomas","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0410","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.tem.2015.07.006","article-title":"Ceramides \u2014 lipotoxic inducers of metabolic disorders","volume":"26","author":"Chaurasia","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0415","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2337\/db12-0686","article-title":"Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance","volume":"62","author":"Boon","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0420","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2337\/db08-1228","article-title":"Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance","volume":"58","author":"Haus","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0425","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1515\/jpem-2012-0407","article-title":"Plasma ceramides are elevated in female children and adolescents with type 2 diabetes","volume":"26","author":"Lopez","year":"2013","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0430","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2337\/diabetes.54.3.591","article-title":"A role for sphingolipids in producing the common features of type 2 diabetes, metabolic syndrome X, and Cushing's syndrome","volume":"54","author":"Summers","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0435","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2007.01.002","article-title":"Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated fat-, and obesity-induced insulin resistance","volume":"5","author":"Holland","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0440","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm.2277","article-title":"Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin","volume":"17","author":"Holland","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0445","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cmet.2015.06.007","article-title":"Targeted induction of ceramide degradation leads to improved systemic metabolism and reduced hepatic steatosis","volume":"22","author":"Xia","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0450","doi-asserted-by":"crossref","first-page":"20148","DOI":"10.1074\/jbc.M412769200","article-title":"Acid ceramidase overexpression prevents the inhibitory effects of saturated fatty acids on insulin signaling","volume":"280","author":"Chavez","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0455","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2353\/ajpath.2008.070564","article-title":"Mechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases","volume":"172","author":"Simonaro","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0460","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1002\/art.38053","article-title":"A lipidomic study of phospholipid classes and species in human synovial fluid","volume":"65","author":"Kosinska","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0465","doi-asserted-by":"crossref","first-page":"e91769","DOI":"10.1371\/journal.pone.0091769","article-title":"Sphingolipids in human synovial fluid \u2014 a lipidomic study","volume":"9","author":"Kosinska","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0470","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1002\/art.34463","article-title":"Interruption of glycosphingolipid synthesis enhances osteoarthritis development in mice","volume":"64","author":"Seito","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0475","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1083\/jcb.201102051","article-title":"A cell-autonomous requirement for neutral sphingomyelinase 2 in bone mineralization","volume":"194","author":"Khavandgar","year":"2011","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0480","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2474-8-29","article-title":"Sphingosine-1-phosphate attenuates proteoglycan aggrecan expression via production of prostaglandin E2 from human articular chondrocytes","volume":"8","author":"Masuko","year":"2007","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0485","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/art.23172","article-title":"Sphingomyelinase decreases type II collagen expression in bovine articular cartilage chondrocytes via the ERK signaling pathway","volume":"58","author":"Gilbert","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0490","doi-asserted-by":"crossref","first-page":"e62715","DOI":"10.1371\/journal.pone.0062715","article-title":"Acid ceramidase maintains the chondrogenic phenotype of expanded primary chondrocytes and improves the chondrogenic differentiation of bone marrow-derived mesenchymal stem cells","volume":"8","author":"Simonaro","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0495","article-title":"Cartilage repair in the inflamed joint: considerations for biological augmentation toward tissue regeneration","author":"Scotti","year":"2015","journal-title":"Tissue Eng. Part B Rev."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0500","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/1947603514534681","article-title":"Cartilage repair with autologous bone marrow mesenchymal stem cell transplantation: review of preclinical and clinical studies","volume":"5","author":"Yamasaki","year":"2014","journal-title":"Cartilage"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0505","article-title":"Acid ceramidase treatment enhances the outcome of autologous chondrocyte implantation in a rat osteochondral defect model","author":"Frohbergh","year":"2015","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0510","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/978-1-4614-0631-0_70","article-title":"Ceramide signaling in retinal degeneration","volume":"723","author":"Chen","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0515","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1167\/iovs.05-1310","article-title":"Ceramide is a mediator of apoptosis in retina photoreceptors","volume":"47","author":"German","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0520","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1471-4159.2006.03977.x","article-title":"Ceramide is the key mediator of oxidative stress-induced apoptosis in retinal photoreceptor cells","volume":"98","author":"Sanvicens","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0525","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1126\/science.1080549","article-title":"Modulating sphingolipid biosynthetic pathway rescues photoreceptor degeneration","volume":"299","author":"Acharya","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0530","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neuron.2007.10.041","article-title":"Cell-nonautonomous function of ceramidase in photoreceptor homeostasis","volume":"57","author":"Acharya","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0535","doi-asserted-by":"crossref","first-page":"20063","DOI":"10.1073\/pnas.0911028106","article-title":"Ceramide kinase regulates phospholipase C and phosphatidylinositol 4, 5, bisphosphate in phototransduction","volume":"106","author":"Dasgupta","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0540","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00417-008-0957-6","article-title":"Ceramide production associated with retinal apoptosis after retinal detachment","volume":"247","author":"Ranty","year":"2009","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0545","doi-asserted-by":"crossref","first-page":"18706","DOI":"10.1073\/pnas.1007644107","article-title":"Inhibition of ceramide biosynthesis preserves photoreceptor structure and function in a mouse model of retinitis pigmentosa","volume":"107","author":"Strettoi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0550","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1086\/381055","article-title":"Mutation of CERKL, a novel human ceramide kinase gene, causes autosomal recessive retinitis pigmentosa (RP26)","volume":"74","author":"Tuson","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0555","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.1167\/iovs.07-0736","article-title":"A common founder mutation of CERKL underlies autosomal recessive retinal degeneration with early macular involvement among Yemenite Jews","volume":"48","author":"Auslender","year":"2007","journal-title":"Invest. Opthalmol. Vis. Sci."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0560","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.bbadis.2014.04.009","article-title":"CERKL interacts with mitochondrial TRX2 and protects retinal cells from oxidative stress-induced apoptosis","volume":"1842","author":"Li","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0565","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1167\/iovs.12-9770","article-title":"Ceramide kinase-like (CERKL) interacts with neuronal calcium sensor proteins in the retina in a cation-dependent manner","volume":"52","author":"Nevet","year":"2012","journal-title":"Invest. Opthalmol. Vis. Sci."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0570","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.exer.2012.10.014","article-title":"Expression and localization of CERKL in the mammalian retina, its response to light-stress, and relationship with NeuroD1 gene","volume":"106","author":"Mandal","year":"2013","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0575","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.exer.2014.05.013","article-title":"Approaches for detecting lysosomal alkalinization and impaired degradation in fresh and cultured RPE cells: evidence for a role in retinal degenerations","volume":"126","author":"Guha","year":"2014","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0580","first-page":"247","article-title":"Ceramide: a potential mediator of apoptosis in human retinal pigment epithelial cells","volume":"42","author":"Barak","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0585","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1091\/mbc.E14-05-1028","article-title":"Cholesterol-mediated activation of acid sphingomyelinase disrupts autophagy in the retinal pigment epithelium","volume":"26","author":"Toops","year":"2015","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0590","article-title":"Role of acid sphingomyelinase in shifting the balance between pro-inflammatory and reparative bone marrow cells in diabetic retinopathy","author":"Chakravarthy","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0595","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1515\/hsz-2014-0290","article-title":"The molecular medicine of acid ceramidase","volume":"396","author":"Frohbergh","year":"2015","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0600","first-page":"163","article-title":"Targeting acid ceramidase sensitises head and neck cancer to cisplatin","volume":"5","author":"Roh","year":"2016"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0605","article-title":"Acid ceramidase in melanoma: expression, localization and effects of pharmacological inhibition","author":"Realini","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0610","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.bbrc.2015.07.047","article-title":"Targeting ceramide metabolic pathway induces apoptosis in human breast cancer cell lines","volume":"464","author":"Vethakanraj","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0615","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0092-8674(00)80091-4","article-title":"Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis","volume":"86","author":"Santana","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0620","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1515\/hsz-2015-0129","article-title":"Preclinical development of a C6-ceramide nanoliposome, a novel sphingolipid therapeutic","volume":"396","author":"Kester","year":"2015","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0625","doi-asserted-by":"crossref","first-page":"11894","DOI":"10.18632\/oncotarget.4180","article-title":"Meta-analysis of organ-specific differences in the structure of the immune infiltrate in major malignancies","volume":"6","author":"Stolli","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0630","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1084\/jem.192.5.601","article-title":"Overexpression of acid ceramidase protects from tumor necrosis factor-induced cell death","volume":"192","author":"Strelow","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0635","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.4049\/jimmunol.167.7.3773","article-title":"Ceramide mediates tumor-induced dendritic cell apoptosis","volume":"167","author":"Kanto","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0640","first-page":"119","article-title":"Ceramide triggers caspase activation during gamma-radiation-induced apoptosis of human glioma cells lacking functional p53","volume":"12","author":"Hara","year":"2004","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0645","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/pros.10350","article-title":"The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts","volume":"58","author":"Samsel","year":"2004","journal-title":"Prostate"},{"key":"10.1016\/j.bbadis.2016.05.001_bb0650","first-page":"1233","article-title":"Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer","volume":"61","author":"Selzner","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0655","doi-asserted-by":"crossref","first-page":"9258","DOI":"10.1021\/acs.jmedchem.5b01188","article-title":"Benzoxazolone carboxamides as potent acid ceramidase inhibitors: synthesis and structure\u2013activity relationship (SAR) studies","volume":"58","author":"Bach","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0660","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1074\/jbc.M115.666909","article-title":"Acid ceramidase in melanoma: expression, localization and effects of pharmacological inhibition","volume":"291","author":"Realini","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2016.05.001_bb0665","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.bbrc.2015.07.047","article-title":"Targeting ceramide metabolic pathway induces apoptosis in human breast cancer cell lines","volume":"464","author":"Vethakanraj","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443916300941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443916300941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T22:15:41Z","timestamp":1655676941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443916300941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":133,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0925443916300941"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2016.05.001","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acid ceramidase and the treatment of ceramide diseases: The expanding role of enzyme replacement therapy","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2016.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}